Literature DB >> 7023410

Bacterial meningitis in the absence of CSF pleocytosis.

D B Fishbein, D L Palmer, K M Porter, W P Reed.   

Abstract

Two cases of acute bacterial meningitis occurred with an absent CSF WBC response. To determine the incidence and clinical characteristics of such patients, 50 consecutive cases of meningitis were reviewed retrospectively. In addition to the two initially noted cases, five additional cases were found. In the seven cases, there were six or fewer cells, but bacteria were detected in the CSF. A distinctive clinical and laboratory syndrome emerged. All seven patients were either old or had Hodgkin's disease or severe alcoholism. All patients had evidence of an overwhelming infection with confusion or nuchal rigidity. As compared with the remaining 45 patients with meningitis and CSF pleocytosis, no fever (less than 38 degrees C), a lower peripheral WBC count, and near-normal CSF glucose and protein concentrations were common. Organisms involved were EScherichia coli in three patients, Pneumococcus in three patients, and mixed anaerobes in patient. A fatal outcome ensued in six of seven patients. Despite the correct choice of an antibacterial agent, doses were late and suboptimal for meningitis. This syndrome is surprisingly common in host-defective cases, has an ominous prognosis, and must be treated expectantly with antimicrobial agents that enter the CSF.

Entities:  

Mesh:

Year:  1981        PMID: 7023410

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  10 in total

Review 1.  Laboratory diagnosis of bacterial meningitis.

Authors:  L D Gray; D P Fedorko
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

2.  Meningococcal meningitis without pleocytosis.

Authors:  M Montejo; M Lizarraga; J Merino; C de la Hoz; J Barron; A Merino; F Layuno; C Aguirre
Journal:  Can Med Assoc J       Date:  1983-06-15       Impact factor: 8.262

3.  Dilemma in Diagnosis of Pyogenic Meningitis in Cerebrospinal Fluid Contaminated with Blood: Does Leucocyte Esterase Test Help?

Authors:  Vani Krishnamurthy; Nidha Nabil; Swathi Muni Reddy; Srinivasa Murthy Doreswamy
Journal:  J Cytol       Date:  2019 Jan-Mar       Impact factor: 1.000

4.  Quality assurance study of bacterial antigen testing of cerebrospinal fluid.

Authors:  D L Kiska; M C Jones; M E Mangum; D Orkiszewski; P H Gilligan
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

5.  Cerebrospinal fluid ceftazidime kinetics in patients with external ventriculostomies.

Authors:  R Nau; H W Prange; M Kinzig; A Frank; A Dressel; P Scholz; H Kolenda; F Sörgel
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

6.  Value of cerebrospinal fluid analysis in the differential diagnosis of meningitis: a study in 710 patients with suspected central nervous system infection.

Authors:  L Lindquist; T Linné; L O Hansson; M Kalin; G Axelsson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-06       Impact factor: 3.267

7.  Bacterial meningitis in the absence of cerebrospinal fluid pleocytosis: A case report and review of the literature.

Authors:  Ryota Hase; Naoto Hosokawa; Makito Yaegashi; Kiyoharu Muranaka
Journal:  Can J Infect Dis Med Microbiol       Date:  2014-09       Impact factor: 2.471

8.  A Rare Case of Sphingomonas paucimobilis Meningitis in the Absence of Cerebrospinal Fluid Pleocytosis.

Authors:  Hassan Mehmood; Noman Khan; Saad Ullah; Asad Ullah; Asghar Marwat
Journal:  J Investig Med High Impact Case Rep       Date:  2018-01-31

9.  Adult pneumococcal meningitis presenting with normocellular cerebrospinal fluid: two case reports.

Authors:  Hiromichi Suzuki; Yasuharu Tokuda; Yoko Kurihara; Masatsune Suzuki; Hidenori Nakamura
Journal:  J Med Case Rep       Date:  2013-12-31

10.  Rapid pathogen identification using a novel microarray-based assay with purulent meningitis in cerebrospinal fluid.

Authors:  Yuting Hou; Xu Zhang; Xiaolin Hou; Ruofen Wu; Yanbai Wang; Xuexian He; Libin Wang; Zhenhai Wang
Journal:  Sci Rep       Date:  2018-10-29       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.